GLP-1 Cost Comparison Guide: Ozempic vs Wegovy vs Mounjaro vs Zepbound Pricing and Savings

May 24, 2026

GLP-1 Cost Comparison Guide: Ozempic vs Wegovy vs Mounjaro vs Zepbound Pricing and Savings

By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante

Key Takeaways

GLP-1 medications are expensive — list prices range from $900-1,350/month without insurance. But actual out-of-pocket costs vary dramatically based on insurance coverage, manufacturer savings programs, pharmacy choice, and whether you're prescribed the diabetes indication vs. the weight management indication.
The same drug molecule can have vastly different costs depending on the brand name and indication: semaglutide is marketed as Ozempic (diabetes) and Wegovy (obesity). Tirzepatide is marketed as Mounjaro (diabetes) and Zepbound (obesity). Insurance coverage often differs by indication.
Multiple strategies exist to reduce costs significantly: manufacturer copay cards, patient assistance programs, compounding pharmacies, international pharmacies, and clinical trials.

List Prices (2024-2025)

Semaglutide Products

Ozempic (semaglutide, diabetes indication): ~$935/month list price. Doses: 0.25mg, 0.5mg, 1mg, 2mg.
Wegovy (semaglutide, weight management): ~$1,350/month list price. Doses: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg.
Rybelsus (oral semaglutide, diabetes): ~$935/month. Oral tablet instead of injection. Lower efficacy for weight loss than injectable.

Tirzepatide Products

Mounjaro (tirzepatide, diabetes indication): ~$1,023/month list price. Doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg.
Zepbound (tirzepatide, weight management): ~$1,060/month list price. Same molecule, obesity indication.

Insurance Coverage Reality

Diabetes Indication (Better Coverage)

Most commercial insurance plans cover Ozempic and Mounjaro for type 2 diabetes with prior authorization.
Typical copay with insurance: $25-150/month.
Medicare Part D covers these for diabetes (though some plans have restrictions or step therapy requirements).

Weight Management Indication (Worse Coverage)

Many insurance plans EXCLUDE weight management drugs. This is changing but slowly.
Medicare does NOT cover Wegovy or Zepbound for weight loss (as of 2025). The Treat and Reduce Obesity Act has been proposed in Congress to change this, but hasn't passed.
Self-pay for weight management: $900-1,350/month without assistance programs.

Cost Reduction Strategies

Manufacturer Savings Programs

Novo Nordisk Savings Card (Ozempic/Wegovy): Eligible commercially insured patients may pay as little as $25/month. Check novocare.com for current offers.
Eli Lilly Savings Card (Mounjaro/Zepbound): Various programs available. Check lilly.com for current offers.
Limitations: Savings cards typically don't work with government insurance (Medicare, Medicaid, Tricare).

Compounding Pharmacies

During FDA-recognized shortage periods, compounding pharmacies can legally produce semaglutide and tirzepatide copies.
Cost: typically $200-500/month (significantly less than brand name).
Caution: Quality varies. Use only pharmacies that are 503B-registered (FDA-regulated outsourcing facilities). Avoid unregulated compounders, especially those selling online without prescriptions.
The legal landscape is evolving: when shortages resolve, compounding pharmacies may lose the right to produce these drugs.

Telehealth Platforms

Companies like Ro, Hims, Noom, and others offer GLP-1 prescriptions + medication at bundled prices.
Cost: $200-500/month typically (using compounded versions during shortage periods).
Advantage: convenient, often includes medical monitoring.
Check: are they prescribing brand-name or compounded medication? What happens to pricing when shortages resolve?

Patient Assistance Programs

Novo Nordisk PAP: For uninsured patients with household income below a threshold. May provide medication free or at reduced cost.
Eli Lilly Lilly Cares: Similar program for Mounjaro/Zepbound.
Application required; income verification typically needed.

Comparison: Efficacy vs. Cost

Weight Loss Efficacy

Tirzepatide (Mounjaro/Zepbound): ~22.5% total body weight loss at maximum dose in clinical trials — the most effective current option.
Semaglutide 2.4mg (Wegovy): ~16.9% total body weight loss in STEP trials.
Semaglutide 1.0-2.0mg (Ozempic): ~10-15% weight loss (lower doses than Wegovy).
Oral semaglutide (Rybelsus): ~5-8% weight loss. Lower efficacy than injectable.

Cost-Effectiveness Perspective

If your goal is maximum weight loss per dollar: tirzepatide (Mounjaro/Zepbound) at the maximum tolerated dose offers the best weight loss per month of cost.
If insurance covers one but not the other: use what's covered. A 15% weight loss on covered semaglutide is better than an unaffordable 22% weight loss on tirzepatide.
If paying out of pocket: compounded semaglutide during shortage periods offers the best value proposition.

🛒 Maximize Your GLP-1 Investment

Whey Protein — You're investing $200-1,350/month in GLP-1 medication. Protect that investment by preserving muscle mass (the primary driver of metabolic rate). Losing muscle during GLP-1 therapy means you'll need the medication longer (or regain weight faster after stopping). Protein supplementation improves the cost-effectiveness of your GLP-1 investment by ensuring the weight you lose is fat, not muscle.
Daily Vitamin — Nutritional deficiencies during GLP-1 therapy can cause symptoms (fatigue, hair loss, brain fog) that lead patients to discontinue the medication prematurely. Micronutrient supplementation prevents these avoidable side effects, keeping you on treatment long enough to reach your goal weight.
Digestive Enzymes — GLP-1 reduces appetite → you eat less → every meal must deliver maximum nutrition. Enzymes ensure 100% of the nutrients in your smaller meals are absorbed. When food intake is reduced, you can't afford to waste any of it to incomplete digestion.

Medical Disclaimer: This article is for educational purposes only. Drug prices change frequently. Verify current pricing with your pharmacy and insurance provider. Compounding pharmacy regulations vary by state and federal policy. Do not purchase GLP-1 medications from unverified online sources. Dr. Adegbola is the founder of Casa de Sante.

Back to blog

Keto. Paleo. No Digestive Triggers. Shop Now

No onion, no garlic – no pain. No gluten, no lactose – no bloat. Low FODMAP certified.

Stop worrying about what you can't eat and start enjoying what you can. No bloat, no pain, no problem.

Our gut friendly keto, paleo and low FODMAP certified products are gluten-free, lactose-free, soy free, no additives, preservatives or fillers and all natural for clean nutrition. Try them today and feel the difference!